ERBB2 and esophageal squamous cell carcinoma: The amplification or over-expression of FGFR1, MET, EGFR, ERBB2, ERBB4, and IL7R was observed in the majority of the patients and has been suggested as main drivers for the ESCC tumorigenesis [47].